This grant, a Funding Opportunity Announcement (FOA), is for institutions and organizations to participate in a cooperative research group, specifically targeting transplantation immunology research. It aims to stimulate interdisciplinary collaborations and integrate new scientific developments and technologies into the field. Three priority areas for research are microbiota, intravital imaging, and targeted therapeutic delivery. By applying these advancements, the grant intends to provide novel insights into the nature of alloimmune responses. The ultimate purpose is to reveal new avenues to diagnose, treat, and prevent allograft rejection or promote immunologic tolerance, thereby significantly advancing transplantation science.
Opportunity ID: 333457
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-21-016 |
| Funding Opportunity Title: | Emerging Science and Technology in Transplantation (U01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 11, 2021 |
| Last Updated Date: | May 11, 2021 |
| Original Closing Date for Applications: | Sep 03, 2021 |
| Current Closing Date for Applications: | Sep 03, 2021 |
| Archive Date: | Oct 09, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Independent school districts Private institutions of higher education Native American tribal governments (Federally recognized) State governments Special district governments For profit organizations other than small businesses Public housing authorities/Indian housing authorities Small businesses Native American tribal organizations (other than Federally recognized tribal governments) County governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications from institutions or organizations to participate in a cooperative research group focused on transplantation immunology research in three priority areas: 1) microbiota; 2) intravital imaging; and 3) targeted therapeutic delivery. The purpose of this FOA is to stimulate the formation of interdisciplinary collaborations and facilitate the application of new scientific developments and technologies to the field of transplant immunology. Applying these advances to transplantation science will provide novel insights into the nature of alloimmune responses and reveal new avenues to diagnose, treat and prevent allograft rejection or promote immunologic tolerance. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-016.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00267052 | Aug 03, 2021 | Sep 03, 2021 | View |
Package 1
Mandatory forms
333457 RR_SF424_2_0-2.0.pdf
333457 PHS398_CoverPageSupplement_5_0-5.0.pdf
333457 RR_OtherProjectInfo_1_4-1.4.pdf
333457 PerformanceSite_2_0-2.0.pdf
333457 RR_KeyPersonExpanded_2_0-2.0.pdf
333457 PHS398_ResearchPlan_4_0-4.0.pdf
333457 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
333457 RR_Budget_1_4-1.4.pdf
333457 RR_SubawardBudget30_1_4-1.4.pdf
333457 PHS398_ModularBudget_1_2-1.2.pdf
333457 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
